ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 255105 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 255105; 2) Community: the network communities that were significantly associated with the response to NSC 255105; 3) Molecule: the relationships between components within communities and NSC 255105; 4) MDR: the compounds that were significantly associated with the NSC 255105.

NSC Compound Enrichment Correlation
NSC 301457 Cycloalkannin 0.0209467683758282 0.6314578
NSC 363787 Kaur-16-en-15-one,1,3,7,11-tetrakis(acetyloxy)-12-hydroxy-, (1.alpha.,3.beta.,7.beta.,11.beta.,12.alpha.)- 0.0209467683758282 0.6963603
NSC 626162 Discorhabdin C . TFA 0.0209467683758282 0.75276992
NSC 629595 Null 0.0209467683758282 0.64702823
NSC 633113 [1,2,3,4]Tetrathiocino[5,6-d:7,8-d']diimidazole- 2,9-dithione, 1,3,8,10-tetraethyl-1,2,3,8,9,10-hexahydro- 0.0209467683758282 0.73388079
NSC 633271 Null 0.0209467683758282 0.48656213
NSC 639501 Cyclopentanone, 2-pentylidene-5-[(1-piperidinyl)methyl]- hydrochloride 0.0209467683758282 0.47032936
NSC 659390 Null 0.0209467683758282 0.61609866
NSC 661581 2-Azabicyclo[16.3.1]docosane, geldanamycin deriv. 0.0209467683758282 0.76540639
NSC 661832 Null 0.0209467683758282 0.3923636
Total:61  Current:29    [First] [Prev] [Next] [Last]